Kentaro Hirao
Overview
Explore the profile of Kentaro Hirao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanyu H, Koyama Y, Horita H, Watanabe S, Sato T, Kanetaka H, et al.
Geriatr Gerontol Int
. 2023 Oct;
23(12):919-924.
PMID: 37905589
Aim: Alzheimer's disease (AD) is a biologically heterogenous disease. In a previous study, we classified 245 patients with probable AD into the typical AD (TAD), limbic-predominant (LP), hippocampal-sparing (HS) and...
2.
Jaime R, Sakurai H, Otakeguchi K, Yamamoto J, Orihara S, Hirose D, et al.
Psychogeriatrics
. 2023 May;
23(4):732-734.
PMID: 37258085
No abstract available.
3.
Hirao K, Yamashita F, Kato H, Kaneshiro K, Tsugawa A, Haime R, et al.
Geriatr Gerontol Int
. 2022 Sep;
22(10):846-850.
PMID: 36058887
Aim: Depressive symptoms are one of the most common neuropsychiatric symptoms in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD), although the pathophysiologies of the depressive symptoms that...
4.
Hanyu H, Koyama Y, Horita H, Aoki T, Sato T, Takenoshita N, et al.
J Alzheimers Dis
. 2022 Apr;
87(2):781-789.
PMID: 35367967
Background: Alzheimer's disease (AD) is a biologically heterogenous disease. Previous studies have reported the existence of various AD subtypes, and the various clinical features of the subtypes. However, inconsistent results...
5.
Hanyu H, Koyama Y, Horita H, Aoki T, Sato T, Kanetaka H, et al.
Curr Alzheimer Res
. 2022 Mar;
19(2):95-103.
PMID: 35227184
Background/objective: Although a large number of studies have been performed on the association between Alzheimer's disease (AD) and type 2 diabetes mellitus (DM), the underlying pathophysiology of AD associated with...
6.
Sato T, Hanyu H, Koyama Y, Horita H, Aoki T, Hirao K, et al.
J Alzheimers Dis
. 2021 Sep;
84(1):273-281.
PMID: 34542077
Background: In Alzheimer's disease (AD) patients, the severity of cognitive impairment is thought to correlate with the degree of brain imaging abnormalities. However, some patients show only mild cognitive deficit,...
7.
Hirao K, Yamashita F, Sakurai S, Tsugawa A, Haime R, Fukasawa R, et al.
Geriatr Gerontol Int
. 2021 Jun;
21(8):644-650.
PMID: 34105230
Aim: White matter hyperintensities (WMH) obtained by magnetic resonance imaging (MRI) have been reported to promote neurodegeneration and cognitive decline in patients with mild cognitive impairment (MCI). However, little is...
8.
Ogata J, Hirao K, Nishioka K, Hayashida A, Li Y, Yoshino H, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33918221
() is a major causative gene of late-onset familial Parkinson's disease (PD). The suppression of kinase activity is believed to confer neuroprotection, as most pathogenic variants of associated with PD...
9.
Hirao K, Yamashita F, Tsugawa A, Haime R, Fukasawa R, Sato T, et al.
J Alzheimers Dis
. 2021 Feb;
80(2):877-883.
PMID: 33579856
Background: White matter hyperintensities (WMH) on MRI have been reported to increase the risk of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD). However, effects of the progression...
10.
Inagawa Y, Shimizu S, Takenoshita N, Tsugawa A, Hirose D, Kanbayashi T, et al.
Psychogeriatrics
. 2020 Nov;
21(1):128-130.
PMID: 33145889
No abstract available.